financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Hold Opinion On Shares Of Ford Motor Company
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Hold Opinion On Shares Of Ford Motor Company
May 26, 2025 3:10 AM

06:20 AM EDT, 05/06/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We maintain a 12-month target of $9, based on a 2026 P/E of 7.8x, a slight premium to historic averages. We lower our adjusted EPS estimates to $0.90 from $1.30 for '25 and to $1.15 from $1.60 for '26. F posts Q1 adjusted EPS of $0.14 vs. $0.49 (-71%), ahead of the $0.02 consensus. The beat was driven by a stronger-than-expected top line, as automotive revenue fell 6.2% to $37.4B ($1.6B ahead of consensus) and adjusted EBIT margin contracted 400 bps to 2.5% F suspended the full year adjusted EBIT guidance it introduced in February of $7.0B-$8.5B. The company estimated a full year adverse tariff impact on adjusted EBIT of $1.5B. From our perspective, it is clear the company faces significant operational and market-related headwinds - even absent tariffs - noting Ford's U.S. market share losses over the past 5-10 years. While Ford's U.S. sales have rebounded so far in 2025 (+3.2% YTD through April), we think serious structural issues remain and we have little confidence in management's ability to execute.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Lowers Opinion On Lucid Group Inc. Shares To Strong Sell From Sell
Research Alert: CFRA Lowers Opinion On Lucid Group Inc. Shares To Strong Sell From Sell
Oct 7, 2025
08:20 AM EDT, 10/07/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our 12-month target of $10. We lower our adjusted EPS estimates to -$11.15 from -$10.50 for 2025 and to -$11.50 from -$11.00 for 2026. LCID posted Q3 vehicle...
Research Alert: CFRA Keeps Sell Opinion On Shares Of Mccormick & Company, Incorporated
Research Alert: CFRA Keeps Sell Opinion On Shares Of Mccormick & Company, Incorporated
Oct 7, 2025
02:30 PM EDT, 10/07/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our 12-month target by $1 to $59, about 19x our FY 26 (Nov.) EPS estimate of $3.12 (down from $3.14; FY 25 raised to $3.03 from $2.97). This...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Constellation Brands Inc.
Research Alert: CFRA Maintains Buy Opinion On Shares Of Constellation Brands Inc.
Oct 7, 2025
11:50 AM EDT, 10/07/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our 12-month target by $10 to $175, based on a 2027 P/E of 13.7x, a steep but justified discount to STZ's 10-year average forward P/E of 21.6x. We...
Research Alert: CFRA Raises Opinion On Health Care To Marketweight From Underweight
Research Alert: CFRA Raises Opinion On Health Care To Marketweight From Underweight
Oct 8, 2025
01:40 PM EDT, 10/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: After Pfizer Inc. (PFE 26 ****) and the U.S. government struck the first Most Favored Nation (MFN) drug pricing deal to lower drug prices in the U.S., we see policy...
Copyright 2023-2025 - www.financetom.com All Rights Reserved